ArticleEcancermedicalscience2024
Representation of female authors in oncology: the Indian perspective.
Article in Ecancermedicalscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medical and biomedical research productivity in Bahrain: an analysis of gender differences and patterns over two decades.Frontiers in research metrics and analytics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite an increasing number of female oncologists, disparities persist in authorship representation of women, especially in high-impact journals. Objective: This study aimed to investigate gender differences in authorship within select high-impact Indian oncology journals over a 5-year period, assessing trends in the gender gap. Methods: Six high-impact Indian oncology journals were selected for analysis. Data on original articles, reviews and editorials published between 2017 and 2022 were collected, including authors' gender, their role as first author or corresponding author and name of the journal. Gender determination was validated through web searches. Descriptive statistics were used to summarize the data and to study the prevalence of female authorship across journals. Results: A total of 2,235 articles were included. Across all journals, 30.4% of authors were female, with Journal of Cancer Research and Treatment exhibiting the highest proportion of female authors (948/2,507; 37.8%). Female authorship increased over time, with first authors rising from 33% to 41%, and corresponding authors from 29.4% to 36.4%. However, disparities persisted, and certain journals exhibited fluctuating trends. Female authorship was higher in original articles (30.9%) compared to reviews (27.8%) and editorials (24.5%). Women comprised 3.5%-24.4% of the editorial boards of the six journals. Conclusion: Female representation, both as authors and editorial board members of Indian oncology journals is disproportionately low. Proactive measures are necessary to address these disparities and promote gender equity in academic publishing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.